An Exploratory Study on the Use of Ivosidenib for the Precise Treatment of Advanced Biliary Tract Malignancies With IDH1 Mutations in the Later Line of Therapy.
Clinical trial NCT07282262 · RECRUITING
Trial details
- NCT number
- NCT07282262
- Sponsor
- Peking Union Medical College Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2026-10-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.